Research gaps in evidence-based contraception guidance: US Medical Eligibility Criteria for Contraceptive Use, 2024, and US Selected Practice Recommendations for Contraceptive Use, 2024

循证避孕指导方面的研究空白:《2024 年美国避孕药具使用医疗资格标准》和《2024 年美国避孕药具使用精选实践建议》

阅读:1

Abstract

The US Centers for Disease Control and Prevention publishes evidence-based contraception guidelines to assist healthcare providers when counseling patients about safe and effective contraceptive use. The US Medical Eligibility Criteria for Contraceptive Use (US MEC) and the US Selected Practice Recommendations for Contraceptive Use (US SPR) have been updated on a regular basis, with the most recent full update published in 2024. This paper provides an overview of research gaps identified throughout the update process and discusses in further depth evidence gaps on several topics, including risk of thrombosis with hormonal contraception, medications for intrauterine device placement, and bleeding irregularities during implant use. Expanded study on these research gaps is needed to bolster guidelines and to improve safe and effective delivery of contraception.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。